Welcome to WeaveGen
Early Detection, Better Outcomes
Bringing early detection for a faster path to recovery
Clinically Validated Solutions
Effective assessment for early detection of disease
Innovative products to improve clinical outcomes and patient lives.
About WeaveGen
We Provide Emerging & Novel Healthcare Solutions
With a customer-centric focus, we aim to bring innovative products to improve clinical outcomes and patient lives. We believe in providing breakthrough solutions that will change the healthcare scene.
- Prevention & Interventions
- Diagnostics & analytics
- Based on the latest research
- Deliver healthcare innovation
- Early detection, better results
*Numbers are applicable to USA & Europe only
*Numbers are applicable to USA & Europe only
OUR products
Explore Our Solution
Early detection kits with greater value, better results, greater accessibility and clarity; more affordable and less complexity and time are required.
Uro17™
Urine tests are based on an immunobiomarker, which plays a role in the malignant tumor cell replication.
Contact Us For More Information
We aim to bring innovative products to improve clinical outcomes and patient lives.
Finding and treating disease at an early stage is important. Being aware of how your body feels, and consulting your doctor is the first step of early detection. When treatment is delayed, there is an increased risk of recovery, further treatment complications, and higher treatment costs. Early detection provides better outcomes by allowing patients to get treatment at the earliest possible phase, which is an effective public health approach in all situations.
latest news
News & Article
UPTM FTA: Early detection of diabetic kidney disease
In diabetic kidney disease, timing is everything. Traditionally,...
2023 ASN Kidney Week Abstract: DNlite IVD103 with CKD and Coronary Artery Disease in Diabetic Nephropathy
A study supported by Bio Preventive Medicine Corp.,...
Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd
Press release to announce that ….